Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Vaccines

  Free Subscription


19.12.2011

1 AIDS
1 Arch Pediatr
3 BMJ
1 Clin Infect Dis
2 Infect Immun
1 J Gen Virol
1 J Immunol
7 J Infect Dis
1 J Pediatr
3 J Virol
2 JAMA
1 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
1 Nat Med
6 Pediatr Infect Dis J
3 Pediatrics
1 Science
27 Vaccine
2 Wkly Epidemiol Rec


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. VAN GULCK E , Vlieghe E, Vekemans M, Van Tendeloo VF, et al
    mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    AIDS. 2011.
    PubMed     Text format     Related articles    Abstract available



    Arch Pediatr

  2. COHEN R , Dufour V, Floret D, Dommergues MA, et al
    [Special report on vaccination week: measles, April No. 4/2011 1].
    Arch Pediatr. 2011;18:932-933.
    PubMed     Text format     Related articles   



    BMJ

  3. DUNCAN CJ , Hill AV
    What is the efficacy of the RTS,S malaria vaccine?
    BMJ. 2011;343:d7728.
    PubMed     Text format     Related articles   


  4. ROUSE AM , Chambers J, Nelson J
    Improving MMR coverage in Birmingham.
    BMJ. 2011;343:d6890.
    PubMed     Text format     Related articles   


  5. HENSKENS LH , Broos N, Hautermans K
    A patient with bilateral shoulder and pelvic girdle aching.
    BMJ. 2011;343:d6233.
    PubMed     Text format     Related articles   



    Clin Infect Dis

  6. SKOWRONSKI DM , Janjua NZ, Sonfack Tsafack EP, Ouakki M, et al
    The Number Needed to Vaccinate to Prevent Infant Pertussis Hospitalization and Death Through Parent Cocoon Immunization.
    Clin Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available



    Infect Immun

  7. BITSAKTSIS C , Iglesias BV, Li Y, Colino J, et al
    Mucosal immunization with an unadjuvanted vaccine that targets S. pneumoniae PspA to human FcgammaRI protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
    Infect Immun. 2011.
    PubMed     Text format     Related articles    Abstract available


  8. LEYSATH CE , Chen KH, Moayeri M, Crown D, et al
    Mouse monoclonal antibodies to anthrax edema factor protect against infection.
    Infect Immun. 2011;79:4609-16.
    PubMed     Text format     Related articles    Abstract available



    J Gen Virol

  9. MAHAPATRA M , Hamblin P, Paton D
    FMD virus epitope dominance in the antibody response of vaccinated animals.
    J Gen Virol. 2011.
    PubMed     Text format     Related articles    Abstract available



    J Immunol

  10. GORDON SN , Kines RC, Kutsyna G, Ma ZM, et al
    Targeting the Vaginal Mucosa with Human Papillomavirus Pseudovirion Vaccines Delivering Simian Immunodeficiency Virus DNA.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



    J Infect Dis

  11. LIAO G , Li R, Li C, Sun M, et al
    Safety and Immunogenicity of Inactivated Poliovirus Vaccine Made From Sabin Strains: A Phase II, Randomized, Positive-Controlled Trial.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available


  12. COCHI SL , Linkins RW
    The Final Phase of Polio Eradication: New Vaccines and Complex Choices.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles   


  13. WAGGIE Z , Geldenhuys H, Sutter RW, Jacks M, et al
    Randomized Trial of Type 1 and Type 3 Oral Monovalent Poliovirus Vaccines in Newborns in Africa.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available


  14. HAMPTON LM , Farley MM, Schaffner W, Thomas A, et al
    Prevention of Antibiotic-Nonsusceptible Streptococcus pneumoniae With Conjugate Vaccines.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available


  15. DESEL C , Dorhoi A, Bandermann S, Grode L, et al
    Recombinant BCG DeltaureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses.
    J Infect Dis. 2011;204:1573-84.
    PubMed     Text format     Related articles    Abstract available


  16. GOWTHAMAN U , Singh V, Zeng W, Jain S, et al
    Promiscuous Peptide of 16 kDa Antigen Linked to Pam2Cys Protects Against Mycobacterium tuberculosis by Evoking Enduring Memory T-Cell Response.
    J Infect Dis. 2011.
    PubMed     Text format     Related articles    Abstract available


  17. CORTESE MM , Barskey AE, Tegtmeier GE, Zhang C, et al
    Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity.
    J Infect Dis. 2011;204:1413-22.
    PubMed     Text format     Related articles    Abstract available



    J Pediatr

  18. ABMAN SH
    Immunologic response to influenza vaccine in at-risk children.
    J Pediatr. 2012;160:A1.
    PubMed     Text format     Related articles   



    J Virol

  19. SCHWENEKER M , Lukassen S, Spath M, Wolferstatter M, et al
    The vaccinia virus O1 protein is required for sustained activation of the extracellular signal-regulated kinase (ERK) 1/2 and promotes viral virulence.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available


  20. QURESHI H , Ma ZM, Huang Y, Hodge G, et al
    Low dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus 5 then immunized with a replication defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the Phase IIb Step trial of a similar HIV-1 vaccine.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available


  21. LI H , Liu J, Carville A, Mansfield KG, et al
    Durable, Mucosal SIV-Specific Effector Memory T Lymphocyte Responses Elicited by Recombinant Adenovirus Vectors in Rhesus Monkeys.
    J Virol. 2011.
    PubMed     Text format     Related articles    Abstract available



    JAMA

  22. HAMPTON T
    Outbreaks spur measles vaccine studies.
    JAMA. 2011;306:2440-2.
    PubMed     Text format     Related articles   


  23. KUEHN BM
    Influential groups propose less frequent cervical cancer screening for most women.
    JAMA. 2011;306:2311-2.
    PubMed     Text format     Related articles   



    MMWR Morb Mortal Wkly Rep


  24. Progress toward poliomyelitis eradication---India, January 2010--September 2011.
    MMWR Morb Mortal Wkly Rep. 2011;60:1482-6.
    PubMed     Text format     Related articles    Abstract available



    N Engl J Med

  25. ATMAR RL , Bernstein DI, Harro CD, Al-Ibrahim MS, et al
    Norovirus vaccine against experimental human Norwalk Virus illness.
    N Engl J Med. 2011;365:2178-87.
    PubMed     Text format     Related articles    Abstract available


  26. CABROL JC
    War, drought, malnutrition, measles--a report from Somalia.
    N Engl J Med. 2011;365:1856-8.
    PubMed     Text format     Related articles   



    Nat Med

  27. SWEENEY KA , Dao DN, Goldberg MF, Hsu T, et al
    A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis.
    Nat Med. 2011 Sep 4. doi: 10.1038/nm.2420.
    PubMed     Text format     Related articles    Abstract available



    Pediatr Infect Dis J

  28. LOUGHLIN J , Mast C, Doherty M, Wang FT, et al
    Post Marketing Evaluation of the Short-term Safety of the Pentavalent Rotavirus Vaccine.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available


  29. LANGLEY JM , Halperin SA, Rubin E, White C, et al
    Safety and Immunogenicity of Two Mixed Primary Infant Immunization Schedules of Pentavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliomyelitis, and Haemophilus influenzae Type b Vaccines at 2, 4, and 6 Months of Age: A Randomized Cont
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available


  30. WROE PC , Lee GM, Finkelstein JA, Pelton SI, et al
    Pneumococcal Carriage and Antibiotic Resistance in Young Children before 13-Valent Conjugate Vaccine.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available


  31. DE SEVILLA MF , Garci JJ, Esteva C, Moraga F, et al
    Clinical Presentation of Invasive Pneumococcal Disease in Spain in the Era of Heptavalent Conjugate Vaccine.
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available


  32. TREGNAGHI M , Zambrano B, Santos-Lima E
    Antibody Persistence Following a Primary Series of a New DTaP-IPV-Hep B-PRP-T Combined Vaccine or Separate DTaP-IPV//PRP approximately T and Hepatitis B Vaccines at 2, 4, and 6 Months of Age and the Effect of a Subsequent DTaP-IPV//PRP approximately T
    Pediatr Infect Dis J. 2011.
    PubMed     Text format     Related articles    Abstract available


  33. BEHARRY MS , Coles MS, Burstein GR
    Adolescent immunization update.
    Pediatr Infect Dis J. 2011;30:787-90.
    PubMed     Text format     Related articles   



    Pediatrics

  34. HAMBIDGE SJ , Ross C, Glanz J, McClure D, et al
    Trivalent Inactivated Influenza Vaccine Is Not Associated With Sickle Cell Crises in Children.
    Pediatrics. 2011.
    PubMed     Text format     Related articles    Abstract available



  35. Poliovirus.
    Pediatrics. 2011;128:805-8.
    PubMed     Text format     Related articles    Abstract available



  36. Recommendations for Prevention and Control of Influenza in Children, 2011-2012.
    Pediatrics. 2011.
    PubMed     Text format     Related articles    Abstract available



    Science

  37. KUPFERSCHMIDT K
    Infectious disease. Taking a new shot at a TB vaccine.
    Science. 2011;334:1488-90.
    PubMed     Text format     Related articles   



    Vaccine

  38. CHABOT DJ , Joyce J, Caulfield M, Cook J, et al
    Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  39. NAITO S , Ito Y, Kiyohara T, Kataoka M, et al
    Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  40. NOUIR NB , Eschbach ML, Piedavent M, Osterloh A, et al
    Vaccination with Strongyloides ratti heat shock protein 60 increases susceptibility to challenge infection by induction of Th1 response.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  41. MCREE AL , Reiter PL, Brewer NT
    Parents' Internet use for information about HPV vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  42. KATA A
    Anti-vaccine activists, Web 2.0, and the postmodern paradigm - An overview of tactics and tropes used online by the anti-vaccination movement.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  43. MICOLI F , Rondini S, Pisoni I, Giannelli C, et al
    Production of a conjugate vaccine for Salmonella enterica serovar Typhi from Citrobacter Vi.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  44. EHRLICH HJ , Berezuk G, Fritsch S, Aichinger G, et al
    Clinical development of a Vero cell culture-derived seasonal influenza vaccine.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  45. HAKIM H , Allison KJ, Van De Velde LA, Li Y, et al
    Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  46. AMBROSE CS , Wu X, Knuf M, Wutzler P, et al
    The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  47. ROPERO-ALVAREZ AM , Whittembury A, Kurtis HJ, Dos Santos T, et al
    Pandemic influenza vaccination: Lessons learned from Latin America and the Caribbean.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  48. MAKOSCHEY B , Ramage C, Reddick D, Fraser S, et al
    Colostrum from cattle immunized with a vaccine based on iron regulated proteins of Mannheimia haemolytica confers partial protection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  49. JOSE PRIYA TA , Lin YH, Wang YC, Yang CS, et al
    Codon changed immobilization antigen (iAg), a potent DNA vaccine in fish against Cryptocaryon irritans infection.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  50. SANDER BB , Rebolj M, Valentiner-Branth P, Lynge E, et al
    Introduction of human papillomavirus vaccination in Nordic countries.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  51. SANCHEZ-PAYA J , Hernandez-Garcia I, Garcia-Roman V, Camargo-Angeles R, et al
    Influenza vaccination among healthcare personnel after pandemic influenza H1N1.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  52. BAHEY-EL-DIN M
    Lactococcus lactis-based vaccines from laboratory bench to human use: An overview.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  53. KIM EH , Choi SY, Kwon MK, Tran TD, et al
    Streptococcus pneumoniae pep27 mutant as a live vaccine for serotype-independent protection in mice.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  54. VERMEULEN JN , Lange JM, Tyring SK, Peters PH, et al
    Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults >/=60 years of age.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  55. GARLAPATI S , Eng NF, Kiros TG, Kindrachuk J, et al
    Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis.
    Vaccine. 2011;29:6540-8.
    PubMed     Text format     Related articles    Abstract available


  56. PALIWAL PK , Bansal A, Sagi SS, Sairam M, et al
    Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella Typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection.
    Vaccine. 2011;29:6532-9.
    PubMed     Text format     Related articles    Abstract available


  57. LI J , Xia J, Tan C, Zhou Y, et al
    Evaluation of the immunogenicity and the protective efficacy of a novel identified immunogenic protein, SsPepO, of Streptococcus suis serotype 2.
    Vaccine. 2011;29:6514-9.
    PubMed     Text format     Related articles    Abstract available


  58. FERGUSON M , Wilkinson DE, Heath A, Matejtschuk P, et al
    The first international standard for antibodies to HPV 16.
    Vaccine. 2011;29:6520-6.
    PubMed     Text format     Related articles    Abstract available


  59. MONTO AS , Black S, Plotkin SA, Orenstein WA, et al
    Response to the 2009 pandemic: Effect on influenza control in wealthy and poor countries.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  60. LIU YV , Massare MJ, Barnard DL, Kort T, et al
    Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  61. SCOTT PD , Meng B, Marriott AC, Easton AJ, et al
    Defective interfering influenza virus confers only short-lived protection against influenza virus disease: Evidence for a role for adaptive immunity in DI virus-mediated protection in vivo.
    Vaccine. 2011.
    PubMed     Text format     Related articles    Abstract available


  62. LIU KY , Shi Y, Luo P, Yu S, et al
    Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model.
    Vaccine. 2011;29:6679-85.
    PubMed     Text format     Related articles    Abstract available


  63. ZHAO K , Wang H, Wu C
    The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8 T cells are augmented in varying degrees by CpG ODN, PolyI:C and R848.
    Vaccine. 2011;29:6670-8.
    PubMed     Text format     Related articles    Abstract available


  64. GAO X , Cai K, Li T, Wang Q, et al
    Novel fusion protein protects against adherence and toxicity of enterohemorrhagic Escherichia coli O157:H7 in mice.
    Vaccine. 2011;29:6656-63.
    PubMed     Text format     Related articles    Abstract available



    Wkly Epidemiol Rec


  65. Progress towards eradicating poliomyelitis: Afghanistan and Pakistan, January 2010-September 2011.
    Wkly Epidemiol Rec. 2011;86:514-20.
    PubMed     Text format     Related articles   



  66. Progress towards eradicating poliomyelitis: India, January 2010-September 2011.
    Wkly Epidemiol Rec. 2011;86:501-7.
    PubMed     Text format     Related articles   



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: